beta-thalassemia

Bluebird bio may finally get a gene therapy approved in the US
Endpoints
Mon, 11/22/21 - 10:28 am
Bluebird Bio
gene therapy
FDA
Zynteglo
beta-thalassemia
priority review
Bluebird's Zynteglo trials set to resume, putting gene therapy back on flight path to FDA filing
Fierce Pharma
Mon, 06/7/21 - 11:09 am
Bluebird Bio
Zynteglo
gene therapy
beta-thalassemia
Bluebird trumpets long-term data from beta-thalassaemia gene therapy
Pharmaforum
Wed, 12/9/20 - 10:40 am
Bluebird Bio
Zinteglo
gene therapy
beta-thalassemia
bluebird bio Prepares for Launch
Motley Fool
Thu, 08/8/19 - 10:22 am
Bluebird Bio
Zynteglo
beta-thalassemia
drug launches
First gene therapy to treat rare blood disease nears European approval
Stat
Fri, 03/29/19 - 10:05 am
Bluebird Bio
Europe
LentiGlobin
gene therapy
beta-thalassemia
Bluebird’s gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
Endpoints
Wed, 04/18/18 - 11:04 pm
Bluebird Bio
beta-thalassemia
gene therapy
Bluebird Reports Early Results From Upgraded Gene Therapy
Xconomy
Fri, 06/23/17 - 09:46 am
Bluebird Bio
LentiGlobin
gene therapy
clinical trials
beta-thalassemia
Sangamo to transfer two gene therapies to Biogen spin-off
BioPharma Dive
Thu, 12/1/16 - 04:24 pm
Sangamo
gene therapy
Biogen
Bioverativ
sickle cell disease
beta-thalassemia
Bluebird Shares Plunge on Waning Effect of Old Gene Therapy
TheStreet.com
Mon, 10/19/15 - 05:43 pm
Bluebird Bio
gene therapy
beta-thalassemia
3 Clinical Trials to Watch As Bluebird Bio Rounds Out 2015
Motley Fool
Mon, 09/14/15 - 08:28 am
clinical trials
Bluebird Bio
HGB-205
HGB-206
HGB-204
sickle cell disease
beta-thalassemia
What's in bluebird bio's Pipeline That Has Investors So Excited?
Motley Fool
Sun, 07/19/15 - 05:35 pm
Bluebird Bio
gene therapy
LentiGlobin
beta-thalassemia
sickle cell disease
A pair of Celgene partners gets on the FDA fast track
Fierce Biotech
Mon, 05/18/15 - 11:16 am
Celgene
FDA
fast track
luspatercept
Acceleron
beta-thalassemia
AG-120
Agios Pharmaceuticals
Gene therapy pioneer Bluebird bags a 'breakthrough' title for lead program
Fierce Biotech
Mon, 02/2/15 - 08:08 am
Bluebird Bio
gene therapy
beta-thalassemia
LentiGlobin BB305
Bluebird Stock Rockets On Gene Therapy Results
Forbes
Mon, 06/16/14 - 10:02 am
Bluebird Bio
beta-thalassemia
Biogen to Develop Blood Medicines in Deal With Sangamo
Bloomberg
Thu, 01/9/14 - 09:33 am
Biogen Idec
Sangamo BioSciences
beta-thalassemia
sickle cell disease
Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic for Beta-thalassemia
Yahoo/PR NewsWire
Fri, 05/24/13 - 10:44 am
Sangamo BioSciences
beta-thalassemia
stem cells
ZFP Therapeutic
Acceleron Receives Two FDA Orphan Designations for ACE-536
Yahoo
Tue, 03/26/13 - 10:34 am
FDA
orphan drugs
ACE-536
Acceleron
beta-thalassemia
myelodysplastic syndromes